Effect of Gastric Bypass vs Best Medical Treatment on Early-Stage Chronic Kidney Disease in Patients With Type 2 Diabetes and Obesity-Reference-Cited by-同舟云学术

Effect of Gastric Bypass vs Best Medical Treatment on Early-Stage Chronic Kidney Disease in Patients With Type 2 Diabetes and Obesity

Published:2020-08-19 Issue:8 Volume:155 Page:e200420
ISSN:2168-6254
Container-title:JAMA Surgery
language:en
Short-container-title:JAMA Surg

Author:

Cohen Ricardo Vitor¹,Pereira Tiago Veiga²³,Aboud Cristina Mamédio¹,Petry Tarissa Beatrice Zanata¹,Lopes Correa José Luis¹,Schiavon Carlos Aurélio⁴,Pompílio Carlos Eduardo¹,Pechy Fernando Nogueira Quirino¹,da Costa Silva Ana Carolina Calmon¹,de Melo Fernanda Lendimuth Gomes¹,Cunha da Silveira Lívia Porto¹,de Paris Caravatto Pedro Paulo¹,Halpern Helio¹,Monteiro Frederico de Lima Jacy¹,da Costa Martins Bruno¹,Kuga Rogerio¹,Palumbo Thais Mantovani Sarian¹,Docherty Neil Gerard⁵⁶,le Roux Carel Wynand⁵⁷

Affiliation:

1. The Center for Obesity and Diabetes, Oswaldo Cruz German Hospital, São Paulo, Brazil

2. Applied Health Research Center, St Michael’s Hospital, Toronto, Ontario, Canada

3. Health Technology Assessment Unit, International Research Center, Oswaldo Cruz German Hospital, São Paulo, Brazil

4. Research Institute, Hospital do Coração, São Paulo, Brazil

5. Diabetes Complications Research Center, UCD Conway Institute, University College Dublin School of Medicine, Dublin, Ireland

6. Institute of Clinical Sciences, Sahlgrenska University Hospital, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden

7. Investigative Medicine, Imperial College London, London, United Kingdom

Publisher

American Medical Association (AMA)

Subject

Surgery

Link

https://jamanetwork.com/journals/jamasurgery/articlepdf/2766660/jamasurgery_cohen_2020_oi_200013_1597783616.42894.pdf

Reference37 articles.

1. Kidney disease and increased mortality risk in type 2 diabetes.;Afkarian;J Am Soc Nephrol,2013

2. Canagliflozin for primary and secondary prevention of cardiovascular events: results from the CANVAS Program (Canagliflozin Cardiovascular Assessment Study).;Mahaffey;Circulation,2018

3. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes.;Marso;N Engl J Med,2016

4. Liraglutide and cardiovascular outcomes in type 2 diabetes.;Marso;N Engl J Med,2016

5. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy.;Perkovic;N Engl J Med,2019

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic and bariatric surgery: an update from 2010;Current Problems in Surgery;2024-11

2. Precision Medicine in Bariatric Procedures;Gastrointestinal Endoscopy Clinics of North America;2024-10

3. The effect of bariatric surgery on diabetes related foot complications among patients with type 2 diabetes: A systematic review;Journal of Diabetes and its Complications;2024-09

4. Reduced Risk of Cardiovascular Diseases after Bariatric Surgery Based on the New PREVENT Equations;2024-08-06

5. The role of metabolic and bariatric surgery on the obesity pandemic in Latin America: A review of current practices and future directions;Obesity Reviews;2024-06-17